Your browser doesn't support javascript.
loading
MODY probability calculator for GCK and HNF1A screening in a multiethnic background population
Tarantino, Roberta Magalhães; Abreu, Gabriella de Medeiros; Fonseca, Ana Carolina Proença de; Kupfer, Rosane; Pereira, Maria de Fátima Carvalho; Campos Júnior, Mario; Zajdenverg, Lenita; Rodacki, Melanie.
  • Tarantino, Roberta Magalhães; Universidade Federal do Rio de Janeiro. Departamento de Medicina Interna. Rio de Janeiro. BR
  • Abreu, Gabriella de Medeiros; Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Genética Humana. Rio de Janeiro. BR
  • Fonseca, Ana Carolina Proença de; Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Genética Humana. Rio de Janeiro. BR
  • Kupfer, Rosane; Instituto Estadual de Diabetes e Endocrinologia do Rio de Janeiro. Rio de Janeiro. BR
  • Pereira, Maria de Fátima Carvalho; Universidade Federal do Rio de Janeiro. Departamento de Patologia Clínica. Rio de Janeiro. BR
  • Campos Júnior, Mario; Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Genética Humana. Rio de Janeiro. BR
  • Zajdenverg, Lenita; Universidade Federal do Rio de Janeiro. Departamento de Medicina Interna. Rio de Janeiro. BR
  • Rodacki, Melanie; Universidade Federal do Rio de Janeiro. Departamento de Medicina Interna. Rio de Janeiro. BR
Arch. endocrinol. metab. (Online) ; 64(1): 17-23, Jan.-Feb. 2020. tab, graf
Article in English | LILACS | ID: biblio-1088775
ABSTRACT
ABSTRACT Objective We aimed to identify the frequency of monogenic diabetes, which is poorly studied in multiethnic populations, due to GCK or HNF1A mutations in patients with suggestive clinical characteristics from the Brazilian population, as well as investigate if the MODY probability calculator (MPC) could help patients with their selection. Subjects and methods Inclusion criteria were patients with DM diagnosed before 35 years; body mass index < 30 kg/m2; negative autoantibodies; and family history of DM in two or more generations. We sequenced HNF1A in 27 patients and GCK in seven subjects with asymptomatic mild fasting hyperglycemia. In addition, we calculated MODY probability with MPC. Results We identified 11 mutations in 34 patients (32.3%). We found three novel mutations. In the GCK group, six cases had mutations (85.7%), and their MODY probability on MPC was higher than 50%. In the HNF1A group, five of 27 individuals had mutations (18.5%). The MPC was higher than 75% in 11 subjects (including all five cases with HNF1A mutations). Conclusion Approximately one third of the studied patients have GCK or HNF1A mutations. Inclusion criteria included efficiency in detecting patients with GCK mutations but not for HNF1A mutations (< 20%). MPC was helpful in narrowing the number of candidates for HNF1A screening.
Subject(s)


Full text: Available Index: LILACS (Americas) Main subject: Diabetes Mellitus, Type 2 / Hepatocyte Nuclear Factor 1-alpha / Glucokinase / Mutation Type of study: Diagnostic study / Observational study / Prevalence study / Prognostic study / Risk factors / Screening study Limits: Adolescent / Adult / Child / Female / Humans / Male Country/Region as subject: South America / Brazil Language: English Journal: Arch. endocrinol. metab. (Online) Journal subject: Endocrinology / Metabolism Year: 2020 Type: Article Affiliation country: Brazil Institution/Affiliation country: Fundação Oswaldo Cruz/BR / Instituto Estadual de Diabetes e Endocrinologia do Rio de Janeiro/BR / Universidade Federal do Rio de Janeiro/BR

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Index: LILACS (Americas) Main subject: Diabetes Mellitus, Type 2 / Hepatocyte Nuclear Factor 1-alpha / Glucokinase / Mutation Type of study: Diagnostic study / Observational study / Prevalence study / Prognostic study / Risk factors / Screening study Limits: Adolescent / Adult / Child / Female / Humans / Male Country/Region as subject: South America / Brazil Language: English Journal: Arch. endocrinol. metab. (Online) Journal subject: Endocrinology / Metabolism Year: 2020 Type: Article Affiliation country: Brazil Institution/Affiliation country: Fundação Oswaldo Cruz/BR / Instituto Estadual de Diabetes e Endocrinologia do Rio de Janeiro/BR / Universidade Federal do Rio de Janeiro/BR